BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening?
bioAffinity Technologies is surging Wednesday as traders digest recent commercial expansion news alongside tight low-float trading dynamics.
Stocks · News reference
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
iSpecimen surged 27.9% premarket on a $4.5M Foldlab AI asset deal; CEA Industries led gainers, while Focus Universal plunged 51.2%.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings
U.S. stocks edged higher, led by the Dow and materials. Ollie’s beat EPS estimates; biotech and AI shares surged, while Tscan plunged 26%.
BioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring
bioAffinity stock trades higher as it advances its CyPath Lung test for post-treatment lung cancer surveillance.
CEA Industries Regains Nasdaq Compliance
CEA Industries Inc. (NASDAQ:BNC) ("CEA Industries," "BNC" or the "Company"), a growth-oriented company focused on managing the world’s largest corporate treasury of BNB, today announced that it
Why Pyxis Tankers Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Shares of Pyxis Tankers Inc (NASDAQ:PXS) rose sharply in pre-market trading after the company reported better-than-expected earnings for the second quarter. The company posted quarterly earnings of 27 cents per
BrenX Shares Halted On Circuit Breaker To The Upside, Stock Now Up 54.49%